This Combined Synopsis/Solicitation opportunity was posted on January 20, 2011. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

65--Amendment to W9114F11T0012 P0001

Awarded

W9114F11T0012Federal

Submission Closed02/08/2011, 05:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Blood Type IVD Reagents and Sera SupplyThis subcontract involves the supply of Blood Type IVD Reagents and Sera to prime contractors supporting Department of Veterans Affairs VISN 22 medical supply contracts. The scope of work includes the manufacture or distribution of ABO reverse typing cells, antibody screening cells, and antibody identification cells, as well as the provision of Lewis Blood Group Substance and full antigen profiles. All delivered reagents must be FDA compliant and accompanied by Certificates of Analysis or Conformance. The contract is managed by the Network Contract Office 22 under NAICS code 325413, with a response deadline set for November 16, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Blood Type IVD Reagents

Solicitation # 36C26227Q0043

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Reagents and consumables for Roche immunostainers

Solicitation # 75N98027Q00026

National Institutes Of Health Olao

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of i-STAT PT Plus Control Reagent Level 1This subcontract involves the procurement and delivery of i-STAT PT Plus Control Reagent Level 1 for coagulation testing to support prime contractors fulfilling Department of Defense supply contracts. The scope of work requires the delivery of two boxes, each containing ten 1.0 mL units, shipped FOB Destination to a performance location in APO 96260-5479. To ensure quality and safety, all supplied reagents must adhere to Regulation 864.7750 Class II requirements and maintain full compliance with Registration, Listing, Labeling, and Good Manufacturing Practices. This requirement is managed under NAICS code 325413 for the Medical Supply Chain MD Surg FSF agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0906

Solicitation SPE2DS-27-T-0906 is a request for quotations from DLA Troop Support for two sets of DXH 500 Series Blood Chemistry Control (NSN 6550-01-688-9090). This assayed whole blood control is used to monitor multi-parameter hematology cell counters and includes abnormal low, normal, and abnormal high components. The items must be stored refrigerated and upright between 2 to 8 degrees Celsius and protected from freezing and overheating. Delivery is required within 20 days after receipt of order, with a required delivery date of October 27, 2026, under FOB Destination terms. The contract imposes strict shelf-life requirements, specifying a non-extendable shelf life of 3 months, with no more than 13 days elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and compliant with RP001 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. Invoicing is to be processed electronically via the Wide Area Workflow system. This is not a small business set-aside, and the procurement falls under NAICS code 325413. Compliance with the Buy American and Balance of Payments Program and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-0950

Solicitation SPE2DS-27-T-0950 is a Request for Quotations issued by the Department of Defense, DLA Troop Support Medical Supply Chain, for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1 (NSN 6550-01-728-5703). This reagent is used for coagulation testing and is compatible with the i-STAT PT Plus cartridge and the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The required delivery date is October 23, 2026, with a delivery window of 83 days after award. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. Items must be delivered within one month of the manufacture date. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking compliant with Medical Marking Standard No. 1. Labels must include the contract/lot number and manufacture or expiration dates. The procurement is not a small business set-aside, though a HUBZone price evaluation preference may be applied. Compliance with the Buy American Act and DFARS domestic material restrictions is required, and electronic invoicing must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

5 days ago

DEADLINE

in 3 days

General Info

Agency

N/A

Contract Value

$179,312.59

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

European Regional Contracting Office ATTN:MCAA E, Building 3705 Landstuhl, Germany APO AE 09180 GE

Set-Aside

NONE

Awardee

ORTHO-CLINICAL DIAGNOSTICS GMBH

Award Issued Date

03/07/2011, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update

PhaseAwarded

PostedJan 7

Combined Synopsis

Notice updatedJan 20

Response deadline changed from Jan 20, 2011 to Feb 8, 2011. The notice title changed. The notice description changed.

AwardedMar 7

Contract was awarded

Submission Closed

02/08/2011, 05:00:00 AM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The solicitation number is W9114F-11-T-0012. This solicitation is issued as a Request for Quotation, which incorporates provisions and clauses for commercial items in effect through Federal Acquisition Circular 2001-14. This is an unrestricted acquisition. The North American Industry Classification System (NAICS) code is 325413. ITEM 0001: 48 KIT; MTS A/B/D/A/B/D Mono GRP 4x12 Order No. MTS081115 BRAND NAME OR EQUAL, Delivery: 16 kits every 4 month. ITEM 0002: 96 KIT; MTS A/B/D Mono & Rev GRP 4x12 Order No. MTS080515 BRAND NAME OR EQUAL, Delivery 32 kits every 4 month. ITEM 0003: 51 KIT; MTS Anti-IGG Card 4x12 Order No. MTS084024 BRAND NAME OR EQUAL, Deliver 17 kits every 4 month. ITEM 0004: 36 KIT; MTS IgG,-C3d Card, Order No. MTS084014 BRAND NAME OR EQUAL, Deliver 12 kit every 4 month. ITEM 0005: 3 KIT; MTS Rh Phenotype Monoclonal Card, Order No. MTS080024, BRAND NAME OR EQUAL, Deliver 1 kit every 4 month. ITEM 0006: 15 KIT; MTS Diluent 2; 5x100ml, Order No. MTS9230 BRAND NAME OR EQUAL, Deliver 5 kit every 4 month. ITEM 0007: 15 KIT; MTS Diluent 2 Plus, 5x100ml, Order No. MTS9330 BRAND NAME OR EQUAL, Deliver 5 kits every 4 month. ITEM 0008: 36 KIT; Blood Banking Reagents; Confidence System Order No. 6902096 BRAND NAME OR EQUAL, Deliver 3 kits every 4 weeks. ITEM 0009: 52 KIT; Suspension for Blood Banking; 0.8% Surgiscreen 3x10ml, Order No. 6902316, BRAND NAME OR EQUAL, Deliver 4 kit every 4 weeks ITEM 0010: 13 KIT;Suspension for Blood Banking; 0.8% Resolve Panel A, 11x3ml, Order No. 6902317, BRAND NAME OR EQUAL, Deliver 1 kit every 4 weeks. ITEM 0011: 36 KIT; Suspension for Blood Banking; 0.8% Affirmagen 2x10ml, Order No. 719201 BRAND NAME OR EQUAL, Deliver 3 kit every 4 weeks. ITEM 0012: 13 KIT; Suspension for Blood Banking; 0.8% Resolve Panel B 11x3ml, Order No. 6902318, BRAND NAME OR EQUAL, Deliver 1 kit every 4 weeks. ITEM 0013: 39 KIT; Suspension for Blood Banking; 3% Coombs Control, Order No 719810 BRAND NAME OR EQUAL, Deliver 3 kits every 4 weeks. ITEM 0014: 12 EA; MTS Buffered Gel Card, Order No. MTS085014, BRAND NAME OR EQUAL, Deliver 4 kits every 4 month. ITEM 0015: 25 EA; Shipping charges for direct shipment to LRMC Pathology Supply, Attn: Kessler, Thomas, BLDG 3738, Room 109, 66849 Landstuhl, Germany ITEM 0016: 12 KIT; Blood Banking Reagent Confidence System, Order No. 6902096 BRAND NAME OR EQUAL, Deliver 1 kit every month. ITEM 0017: 24 KIT; Suspension for Blood Banking; 0.8% Surgiscreen 3x10ml, Order No. 6902316 BRAND NAME OR EQUAL, Deliver 2 kit per month. ITEM 0018: 12 KIT; Suspension for Blood Banking; 0.8% Resolve Panel A, Order No. 6902317 BRAND NAME OR EQUAL, Deliver 1 kit per month. ITEM 0019: 24 KIT; Suspension for Blood Banking; 0.8 Affirmagen 2x10ml, Order No. 719201 BRAND NAME OR EQUAL, Deliver 2 kits per month. ITEM 0020: 12 KIT; Suspension for Blood Banking; 0.8% Resolve Panel B, 11x3ml, Order No. 6902318 BRAND NAME OR EQUAL, Deliver 1 kit per month. ITEM 0021: 24 KIT; Suspension for Blood Banking; 3% Coombs Control, Order No. 719810 BRAND NAME OR EQUAL, Deliver 2 kit per month. ITEM 0022: 24 EA; Shipping Charges for direct shipment to Vicenza, Clinica Americana/Lab., Caserma Ederle, Viale della Pace 264, Edificio 113, 36100 Vicenza, Italy. Line Items 0001-0014 Ship door-to-door to: Landstuhl Regional Medical Center LRMC Pathology Supply Bldg 3738 66849 Landstuhl, Germany Line Items 0016-0021 Ship door-to-door to: USA Health Clinic Vicenza Rigoberto Miranda Via Aldo Moro Bldg 113, Rm 328 Attn: Medical Supply Office 36100 Vicenza, Italy The following Federal Aquisition Regulation (FAR) clauses and provisions apply to this acquisition: CLAUSES INCORPORATED BY REFERENCE 52.204-10 Reporting Executive Compensation and First -Tier Subcontract Awards - JUL 2010 52.209-6 Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment - SEP 2006 52.211-6 Brand Name or Equal 52.212-4 Contract Terms and Conditions--Commercial Items - MAR 2009 52.222-19 Child Labor--Cooperation with Authorities and Remedies - AUG 2009 52.223-18 Contractor Policy to Ban Text Messaging While Driving - SEP 2010 52.225-13 Restrictions on Certain Foreign Purchases - JUN 2008 52.229-6 Taxes--Foreign Fixed-Price Contracts - JUN 2003 52.232-17 Interest - OCT 2008 52.232-33 Payment by Electronic Funds Transfer--Central Contractor Registration - OCT 2003 52.232-38 Submission of Electronic Funds Transfer Information with Offer- MAY 1999 52.233-4 Applicable Law for Breach of Contract Claim - OCT 2004 52.247-32 F.O.B. Origin, Freight Prepaid- FEB 2006 252.203-7000 Requirements Relating to Compensation of Former DoD Officials - JAN 2009 252.203-7002 Requirement to Inform Employees of Whistelblower Rights - JAN 2009 252.225-7041 Correspondence in English - JUN 1997 252.229-7000 Invoices Exclusive of Taxes or Duties - JUN 1997 252.229-7002 Customs Exemptions (Germany) - JUN 1997 252.232-7003 Electronic Submission of Payment Requests and Receiving Reports - MAR 2008 252.232-7008 Assignment of Claims (Overseas)- JUN 1997 252.232-7010 Levies on Contract Payments - DEC 2006 252.233-7001 Choice of Law (Overseas)- JUN 1997 52.214-34 Submission of Offers in the English Language - APR 1991 52.212-3 Offeror Representations and Certifications-Commercial Items ALT I - APR 2002 52.212-5 Contract Terms and Conditions required to implement Statutes or Executive Orders - Commercial Items - DEC 2009 (Deviation) 52.252-1 Solicitation Provisions incorporated by Reference - FEB 1998 52.252-2 Clauses incorporated by Reference - FEB 1998 252.212-7001 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Applicable to Defense Acquisitions of Commercial Items - JUL 2009 252.225-7043 Antiterrorism/Force Protection Policy for Defense Contractors Outside the United States - MAR 2006 252.229-7001 Tax Relief - ALT I - JUN 1997 252.229-7003 Tax Exemptions (Italy) - JAN 2002 INVOICING INSTRUCTIONS WAWF/DFAS ADDENDUM TO 52.212-4 ADDENDUM TO 52.212-1 52.212-1 Instructions to Offerors--Commercial Items - JUN 2008 The following paragraphs are hereby ammended: Para (a) Does not apply to this RFQ. Para (b) Replace subparagraph (4) with the following: (4) Technical Factor. The vendor must explain how you will comply with the requirements in the request for quote by submitting a written quote which describes: Salient Characteristics-Standard -- Acceptable -- Unacceptable 1. Quoted products must be compatible with GEL based Micro Typing System. 2. Quoted products must be FDA approved 3. Quoted products must be able to be shipped in incremental shipments to Medical Facility in Germany and Italy. Failure to receive an acceptable rating of any of the three (3) technical factors will result in an unacceptable technical rating unless the error(s), deficiencey (ies) or omission (s) can be corrected. All CLINs shall be priced. If you fail to price all CLINs, your quote will not be considered for award. Para (c) Change 30 to 60. Para (d) Does not apply to this request for quote (RFQ) Para (i) Does not apply to the RFQ. Add the following: Para (m) Quotes shall describe how your system contains the three salient characteristics and is an equal to the Ortho Diagnostics Blood Bank supplies. Para (n) Electronic Quotes. Vendors may submit electronic quotes in response to this RFQ. The quote must arrive by the time specified in the RFQ to the following email address: contact@example.gov. Vendors may call Christine Bauer-Newland 06371-86-7597 to verify receipt of quote. If the vendor chooses to email the quote, the Government will not be responsible for any failure of transmission or receipt of the quote, or any failure of the vendor to verify receipt of the emailed quote. Para (o) Questions. Prospective vendors are strongly encouraged to submit any questions regarding this RFQ two days before closing date of quote submission by e-mail to contact@example.gov. All questions received will be answered officially through an amendment for distribution to all prospective vendors. Acquisition Procedure: This is a commercial item under FAR Part 12 and the acquisition procedures to be used for this purchase will be in accordance with FAR Part 13. (End of Provision) 52.212-2 Evaluation--Commercial Items - JAN 1999 SPECIAL NOTE: All offerors must be registered in the Central Contractor Registration (CCR) prior to award, and lack of registration shall make an offer ineligible for award. Offerors may obtain information on registration and annual confirmation requirements by calling +1 (555) 000-0000 or via Internet at http://www.ccr.gov/. All quotes are due 8 Feb 2011 before 5pm Central European Time. Offers may be sent via email to contact@example.gov, or faxed to 011-49-6371-86-8070. The point of contact for this acquisition is Christine Bauer-Newland, phone # 011 49 6371 86 7597.